- Vocera Communcations stock soared 26% following acquisition from Stryker
- The merger comes as a move to streamline industry goals from two market leaders
The stock price of Vocera Communications (NYSE: VCRA) soared over 26% in Thursday’s early trading, with investors reacting kindy to news that the company will be acquired by medical technology company Stryker, which is showing a daily loss of just over 1%.
The definitive merger will involve the entire purchase of all issued and outstanding shares of Vocera’s common stock for a price of $79.25 – a sizeable premium on Wednesday’s closing price. The total value of the deal stands at around $3.09B – including convertible notes.
Acquisitions are a favored route for many medical tech companies. Like any other industry, it allows for further expansion and integration of industry expertise, whilst capitalizing on an existing model that provides foundations for consistent growth. Vocera’s portfolio directly complements Stryker’s medical division – driving efficiency in a critical sector.
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
See: The Best Healthcare Stocks To Buy
Kevin Lobo, Chair & CEO of Stryker stated:
“This acquisition underscores our commitment and focus on our customer…Vocera will help Stryker significantly accelerate our digital aspirations to improve the lives of caregivers and patients.”
Brent Lang, CEO of Vocera expressed a similar opinion:
“Today’s milestone represents an exciting opportunity for Vocera given the clear alignment of mission, goals, and culture between our two organizations and our ability to drive even greater economic and clinical value for our customers”
VCRA stock is consolidating around gains of 26.5%, with price trading just above the $79 level.